NR565 Week 3 Study Outline
NR565 Week 3 Study Outline Many questions are written to assess your clinical application of the material from the textbook, in real-world scenarios. Chapter 14: Drugs Affecting the Autonomic Nervous System Drug classes: Adrenergic agonists-SNS Promote or mimic the release of norepinephrine or epinephrine by binding to alpha 1&2, and beta 1&2 receptors (norepinephrine works on alpha & beta 1) (epinephrine works on all 4) Alpha2 Agonists: Central-Clonidine/Guanfacine, Methyldopa (inhibit release of norepinephrine resulting in the inhibition of excitatory cardiovascular neurons) Adrenergic antagonists- Directly or indirectly block adrenergic receptors by decreasing norepinephrine release in the SNS Alpha1 Antagonists- doxazosin/Cardura, prazosin/Minipress, terazosin/Hytrin, tamsulosin/Flomax, alfuzosin/Uroxatrol, silodosin/Rapoflo (Blocks catecholamines at the postsynaptic alpha1 in vascular smooth muscle, bladder neck, and prostate lowering BP and relieving outflow obstruction thru decreased arterial and venous vasoconstriction ) NSAIDS can diminish effectiveness Beta-adrenergic antagonists/blockers- atenolol/Tenormin, metoprolol/Lopressor, nadolol/Corgard, nebivolol/Bystolic, timolol/ Blocadren (Used to treat cardiac disorders, compete with catecholamine for beta receptor sites/hence beta blocker) Beta1 affects: Cardiac-decrease HR/contractility/conduction Renal- reduces release of renin Beta 2 affects: Respiratory- contraindicated for asthma patients
Información del documento
- Subido en
- 6 de febrero de 2022
- Número de páginas
- 3
- Escrito en
- 2022/2023
- Tipo
- Examen
- Contiene
- Preguntas y respuestas